Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Mk-8998
2. 953778-58-0
3. (r)-2-(4-isopropylphenyl)-n-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide
4. Jzp385
5. Cx-8998
6. Suvecaltamide [usan]
7. Jzp-385
8. Mia4wmp8qn
9. Chembl1684950
10. Mk8998
11. 2-(4-propan-2-ylphenyl)-n-[(1r)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide
12. Benzeneacetamide, 4-(1-methylethyl)-n-((1r)-1-(5-(2,2,2-trifluoroethoxy)-2-pyridinyl)ethyl)-
13. Mk-8998 Free Base
14. 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide
15. 2-(4-isopropylphenyl)-n-[(1r)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide
16. Unii-mia4wmp8qn
17. Suvecaltamide [inn]
18. Suvecaltamide [who-dd]
19. Schembl1065999
20. Gtpl12648
21. Glxc-10813
22. Bcp18693
23. Ex-a2479
24. Bdbm50192668
25. Who 11291
26. Akos032945005
27. Compound 1 [pmid: 27579577]
28. Compound 1 [pmid: 34582192]
29. Cs-6198
30. Ac-35480
31. Bs-17962
32. Cid 24765479
33. Mk-8998?
34. Db-362320
35. Hy-101096
36. C77290
37. A922518
38. 4-(1-methylethyl)-n-((1r)-1-(5-(2,2,2-trifluoroethoxy)-2-pyridinyl)ethyl)benzeneacetamide
| Molecular Weight | 380.4 g/mol |
|---|---|
| Molecular Formula | C20H23F3N2O2 |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 51.2 |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 463 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
37
PharmaCompass offers a list of Suvecaltamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Suvecaltamide manufacturer or Suvecaltamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Suvecaltamide manufacturer or Suvecaltamide supplier.
PharmaCompass also assists you with knowing the Suvecaltamide API Price utilized in the formulation of products. Suvecaltamide API Price is not always fixed or binding as the Suvecaltamide Price is obtained through a variety of data sources. The Suvecaltamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Suvecaltamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Suvecaltamide, including repackagers and relabelers. The FDA regulates Suvecaltamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Suvecaltamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Suvecaltamide supplier is an individual or a company that provides Suvecaltamide active pharmaceutical ingredient (API) or Suvecaltamide finished formulations upon request. The Suvecaltamide suppliers may include Suvecaltamide API manufacturers, exporters, distributors and traders.
Suvecaltamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Suvecaltamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Suvecaltamide GMP manufacturer or Suvecaltamide GMP API supplier for your needs.
A Suvecaltamide CoA (Certificate of Analysis) is a formal document that attests to Suvecaltamide's compliance with Suvecaltamide specifications and serves as a tool for batch-level quality control.
Suvecaltamide CoA mostly includes findings from lab analyses of a specific batch. For each Suvecaltamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Suvecaltamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Suvecaltamide EP), Suvecaltamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Suvecaltamide USP).
